The molecular biology of renal cancer: another piece of the puzzle

Affiliations

¹ Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh, UK; Scottish Collaboration on Translational Research into Renal Cell Cancer, UK. Electronic address: grant.stewart@ed.ac.uk.
² Scottish Collaboration on Translational Research into Renal Cell Cancer, UK; School of Medicine, University of St Andrews, St Andrews, UK.
³ Department of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
⁴ Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.

Editorial

Grant D Stewart et al. Eur Urol. 2014 Jul.

. 2014 Jul;66(1):85-6.

doi: 10.1016/j.eururo.2014.03.004. Epub 2014 Mar 14.

¹ Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh, UK; Scottish Collaboration on Translational Research into Renal Cell Cancer, UK. Electronic address: grant.stewart@ed.ac.uk.
² Scottish Collaboration on Translational Research into Renal Cell Cancer, UK; School of Medicine, University of St Andrews, St Andrews, UK.
³ Department of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
⁴ Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.

No abstract available

Comment on

ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.
Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WK. Brooks SA, et al. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035. Epub 2014 Feb 25. Eur Urol. 2014. PMID: 24613583 Free PMC article.